arrow
T

Thomas F. Gajewski

university of chicago
H指数:95
被引数:5.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma

Monson, K.R.; Ferguson, R.; Handzlik, J.E.; Morales, L.; Xiong, J.; Chat, V.; Dagayev, S.; Khodadadi-Jamayran, A.; Simpson, D.; Kazlow, E.; 等. 继承的线粒体遗传学作为预测黑色素瘤免疫检查点抑制疗效的指标。Nat. Med. 2025, 31, 2385–2396. [Google Scholar] [CrossRef]

2025-06-050
OAAI
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition

种系免疫调节表达与检查点抑制引起的免疫相关毒性相关的数量性状基因座 (ieqtl)

2023-08-014
OA
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)

黑色素瘤的观点: 黑色素瘤桥会议报告 (2022年12月1至3日-意大利那不勒斯)

2023-07-282
OAAI
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas

SEA-CD40的1期剂量递增研究: 非岩藻糖基化CD40激动剂,用于晚期实体瘤和淋巴瘤

2023-06-2910
OAAI
Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents

新型冠状病毒肺炎死者肺引流淋巴结中的淋巴凝结和中性粒细胞细胞外诱捕器

2022-12-277
OAAI
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade

高度非整倍体非小细胞肺癌显示出对同时放射和免疫检查点阻断的反应性增强

2022-11-2844
PRE
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity

严重新型冠状病毒肺炎诱导针对血管紧张素II的自身抗体,其与血压失调和疾病严重程度相关

2022-10-0728
OAAI
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd-4th, 2021, Italy)

黑色素瘤的观点: 黑色素瘤桥会议报告 (意大利2021年12月2至4日)

2022-09-042
OAAI
MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable stage IIIB-IVM1c melanoma (MEL)

MASTERKEY-265: talimogene laherparepvec (T) 联合pembrolizumab (P) 治疗不可切除期IIIB-IVM1c黑色素瘤 (MEL) 的III期随机安慰剂 (Pbo) 对照研究

2021-09-0133
OAAI